

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 5.38708216 |
| 2 | exocrine pancreas development (GO:0031017) | 5.23378794 |
| 3 | lymph vessel development (GO:0001945) | 4.76610201 |
| 4 | collagen fibril organization (GO:0030199) | 4.22717864 |
| 5 | heart trabecula formation (GO:0060347) | 4.07772970 |
| 6 | negative regulation of protein localization to cell surface (GO:2000009) | 4.05174145 |
| 7 | coronary vasculature morphogenesis (GO:0060977) | 4.05042159 |
| 8 | cardiac myofibril assembly (GO:0055003) | 4.01002293 |
| 9 | keratan sulfate catabolic process (GO:0042340) | 3.88509069 |
| 10 | heart valve formation (GO:0003188) | 3.85036432 |
| 11 | endocardial cushion morphogenesis (GO:0003203) | 3.78960470 |
| 12 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.78303471 |
| 13 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 3.71914172 |
| 14 | sarcomere organization (GO:0045214) | 3.71491925 |
| 15 | positive regulation of glycolytic process (GO:0045821) | 3.71481423 |
| 16 | positive regulation of respiratory burst (GO:0060267) | 3.64919906 |
| 17 | positive regulation of glycogen biosynthetic process (GO:0045725) | 3.58185095 |
| 18 | lung lobe morphogenesis (GO:0060463) | 3.56589917 |
| 19 | endothelial cell morphogenesis (GO:0001886) | 3.56045596 |
| 20 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.53202823 |
| 21 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 3.51784038 |
| 22 | L-serine transport (GO:0015825) | 3.49349084 |
| 23 | myofibril assembly (GO:0030239) | 3.45166447 |
| 24 | Notch signaling involved in heart development (GO:0061314) | 3.43947971 |
| 25 | notochord development (GO:0030903) | 3.40933586 |
| 26 | protein heterotrimerization (GO:0070208) | 3.37549773 |
| 27 | plasma membrane repair (GO:0001778) | 3.37208014 |
| 28 | trabecula formation (GO:0060343) | 3.36628420 |
| 29 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 3.34618814 |
| 30 | cartilage condensation (GO:0001502) | 3.33264336 |
| 31 | cell aggregation (GO:0098743) | 3.33264336 |
| 32 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.32174494 |
| 33 | chondrocyte development (GO:0002063) | 3.31234945 |
| 34 | regulation of skeletal muscle contraction (GO:0014819) | 3.29390017 |
| 35 | cardiac muscle cell development (GO:0055013) | 3.28907393 |
| 36 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.27224425 |
| 37 | cardiac cell development (GO:0055006) | 3.26511216 |
| 38 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.26330549 |
| 39 | atrioventricular valve morphogenesis (GO:0003181) | 3.25934047 |
| 40 | glomerular basement membrane development (GO:0032836) | 3.22999594 |
| 41 | mesenchymal cell development (GO:0014031) | 3.21872878 |
| 42 | type B pancreatic cell proliferation (GO:0044342) | 3.20390979 |
| 43 | heart valve morphogenesis (GO:0003179) | 3.19541837 |
| 44 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.18658175 |
| 45 | mesenchyme morphogenesis (GO:0072132) | 3.16517629 |
| 46 | positive regulation of glycogen metabolic process (GO:0070875) | 3.15534733 |
| 47 | endothelial tube morphogenesis (GO:0061154) | 3.13718967 |
| 48 | morphogenesis of an endothelium (GO:0003159) | 3.13718967 |
| 49 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.13089879 |
| 50 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.11489608 |
| 51 | ventricular cardiac muscle cell development (GO:0055015) | 3.11253597 |
| 52 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.10785024 |
| 53 | serine transport (GO:0032329) | 3.08709651 |
| 54 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.08657181 |
| 55 | lung vasculature development (GO:0060426) | 3.06752777 |
| 56 | positive regulation of mitochondrial fission (GO:0090141) | 3.05937155 |
| 57 | atrial septum morphogenesis (GO:0060413) | 3.02956197 |
| 58 | positive regulation of cartilage development (GO:0061036) | 3.02746532 |
| 59 | muscle tissue morphogenesis (GO:0060415) | 3.01790756 |
| 60 | cardiac epithelial to mesenchymal transition (GO:0060317) | 2.99628501 |
| 61 | muscle filament sliding (GO:0030049) | 2.99317644 |
| 62 | actin-myosin filament sliding (GO:0033275) | 2.99317644 |
| 63 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 2.98809237 |
| 64 | cardiac right ventricle morphogenesis (GO:0003215) | 2.96829900 |
| 65 | ear development (GO:0043583) | 2.96285514 |
| 66 | Notch receptor processing (GO:0007220) | 2.95728232 |
| 67 | limb bud formation (GO:0060174) | 2.94855065 |
| 68 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 2.93753815 |
| 69 | cell proliferation involved in kidney development (GO:0072111) | 2.93416498 |
| 70 | neural crest cell development (GO:0014032) | 2.92643424 |
| 71 | lymphangiogenesis (GO:0001946) | 2.91033574 |
| 72 | glomerular filtration (GO:0003094) | 2.90194576 |
| 73 | Golgi transport vesicle coating (GO:0048200) | 2.89267752 |
| 74 | COPI coating of Golgi vesicle (GO:0048205) | 2.89267752 |
| 75 | actin-mediated cell contraction (GO:0070252) | 2.88417268 |
| 76 | growth hormone secretion (GO:0030252) | 2.88322314 |
| 77 | renal filtration (GO:0097205) | 2.87754632 |
| 78 | positive regulation of osteoblast proliferation (GO:0033690) | 2.86836115 |
| 79 | regulation of actin filament-based movement (GO:1903115) | 2.86582365 |
| 80 | positive regulation of chondrocyte differentiation (GO:0032332) | 2.86076634 |
| 81 | cardiac muscle cell proliferation (GO:0060038) | 2.84878702 |
| 82 | modulation by virus of host morphology or physiology (GO:0019048) | 2.84453183 |
| 83 | cell proliferation involved in metanephros development (GO:0072203) | 2.82412980 |
| 84 | skin morphogenesis (GO:0043589) | 2.82188700 |
| 85 | collagen metabolic process (GO:0032963) | 2.81720617 |
| 86 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.81200040 |
| 87 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.79493507 |
| 88 | regulation of protein localization to cell surface (GO:2000008) | 2.76316886 |
| 89 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 2.75792322 |
| 90 | negative regulation of cartilage development (GO:0061037) | 2.75356490 |
| 91 | regulation of striated muscle cell apoptotic process (GO:0010662) | 2.75338574 |
| 92 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.74671592 |
| 93 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.74050057 |
| 94 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.73922617 |
| 95 | hemidesmosome assembly (GO:0031581) | 2.73808784 |
| 96 | gap junction assembly (GO:0016264) | 2.73229591 |
| 97 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.73098982 |
| 98 | short-term memory (GO:0007614) | 2.72956186 |
| 99 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.70554540 |
| 100 | collagen catabolic process (GO:0030574) | 2.70057550 |
| 101 | regulation of vasculogenesis (GO:2001212) | 2.69452848 |
| 102 | striated muscle hypertrophy (GO:0014897) | 2.68544042 |
| 103 | positive regulation of heart rate (GO:0010460) | 2.68024305 |
| 104 | actomyosin structure organization (GO:0031032) | 2.67508686 |
| 105 | protein heterotetramerization (GO:0051290) | 2.67040173 |
| 106 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.66851701 |
| 107 | male sex determination (GO:0030238) | 2.66818197 |
| 108 | positive regulation of extracellular matrix organization (GO:1903055) | 2.66741838 |
| 109 | glycine transport (GO:0015816) | 2.66281758 |
| 110 | chondrocyte proliferation (GO:0035988) | 2.64855448 |
| 111 | aorta morphogenesis (GO:0035909) | 2.64057675 |
| 112 | stem cell development (GO:0048864) | 2.62172875 |
| 113 | regulation of heart morphogenesis (GO:2000826) | 2.61957331 |
| 114 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.61620848 |
| 115 | glomerulus development (GO:0032835) | 2.59028674 |
| 116 | cardiac muscle hypertrophy (GO:0003300) | 2.58576269 |
| 117 | cell surface receptor signaling pathway involved in heart development (GO:0061311) | 2.58542878 |
| 118 | cAMP biosynthetic process (GO:0006171) | 2.57980884 |
| 119 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.57938980 |
| 120 | extracellular matrix assembly (GO:0085029) | 2.57891972 |
| 121 | regulation of cardioblast differentiation (GO:0051890) | 2.56219917 |
| 122 | activation of protein kinase B activity (GO:0032148) | 2.55437003 |
| 123 | ventricular septum morphogenesis (GO:0060412) | 2.55238885 |
| 124 | trabecula morphogenesis (GO:0061383) | 2.55152432 |
| 125 | endothelium development (GO:0003158) | 2.54468139 |
| 126 | axon extension involved in axon guidance (GO:0048846) | 2.54421917 |
| 127 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.54421917 |
| 128 | multicellular organismal metabolic process (GO:0044236) | 2.53563758 |
| 129 | surfactant homeostasis (GO:0043129) | 2.52729959 |
| 130 | multicellular organismal catabolic process (GO:0044243) | 2.50427222 |
| 131 | basement membrane organization (GO:0071711) | 2.50331833 |
| 132 | regulation of smooth muscle cell differentiation (GO:0051150) | 2.49530937 |
| 133 | positive regulation of heart contraction (GO:0045823) | 2.49105942 |
| 134 | negative regulation of fatty acid transport (GO:2000192) | 2.48492091 |
| 135 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.47999283 |
| 136 | regulation of chondrocyte differentiation (GO:0032330) | 2.47899390 |
| 137 | regulation of cartilage development (GO:0061035) | 2.47316637 |
| 138 | cardiac ventricle morphogenesis (GO:0003208) | 2.46953622 |
| 139 | blood vessel maturation (GO:0001955) | 2.45528705 |
| 140 | cardiac muscle contraction (GO:0060048) | 2.45064498 |
| 141 | extracellular fibril organization (GO:0043206) | 2.43437916 |
| 142 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.43434261 |
| 143 | positive regulation of glucose import (GO:0046326) | 2.41747456 |
| 144 | response to BMP (GO:0071772) | 2.40471167 |
| 145 | cellular response to BMP stimulus (GO:0071773) | 2.40471167 |
| 146 | vasculature development (GO:0001944) | 2.39824807 |
| 147 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.39189846 |
| 148 | positive regulation of vascular permeability (GO:0043117) | 2.38070210 |
| 149 | positive regulation of urine volume (GO:0035810) | 2.35574871 |
| 150 | establishment of planar polarity (GO:0001736) | 2.35275959 |
| 151 | establishment of tissue polarity (GO:0007164) | 2.35275959 |
| 152 | cardiac chamber morphogenesis (GO:0003206) | 2.34431831 |
| 153 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.33074523 |
| 154 | gamma-aminobutyric acid transport (GO:0015812) | 2.31725984 |
| 155 | mesonephros development (GO:0001823) | 2.29438552 |
| 156 | maternal placenta development (GO:0001893) | 2.29287527 |
| 157 | heart trabecula morphogenesis (GO:0061384) | 2.27989867 |
| 158 | fibroblast migration (GO:0010761) | 2.26299206 |
| 159 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.25999233 |
| 160 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.24692432 |
| 161 | amyloid precursor protein catabolic process (GO:0042987) | 2.24424502 |
| 162 | regulation of mitochondrial fission (GO:0090140) | 2.24359045 |
| 163 | lens fiber cell development (GO:0070307) | 2.23595575 |
| 164 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.22323232 |
| 165 | ephrin receptor signaling pathway (GO:0048013) | 2.22170620 |
| 166 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.22099360 |
| 167 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.21694186 |
| 168 | negative regulation of endothelial cell migration (GO:0010596) | 2.20693090 |
| 169 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.20182092 |
| 170 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.20061099 |
| 171 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.19864345 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 5.33242743 |
| 2 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 4.61870814 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.74524847 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.33933979 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.73993358 |
| 6 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.68369913 |
| 7 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.62443671 |
| 8 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.40762100 |
| 9 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.34687836 |
| 10 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.31990174 |
| 11 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.14164471 |
| 12 | CJUN_26792858_Chip-Seq_BT549_Human | 2.13505392 |
| 13 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.13151021 |
| 14 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.06637681 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.03155354 |
| 16 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.00574917 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.99396142 |
| 18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.99367082 |
| 19 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.99029140 |
| 20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.94371434 |
| 21 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.91345364 |
| 22 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.90216585 |
| 23 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.85985157 |
| 24 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.85135531 |
| 25 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.81988982 |
| 26 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.81988982 |
| 27 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.81608134 |
| 28 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.80602955 |
| 29 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.80602955 |
| 30 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.78934439 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.78508017 |
| 32 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.76628936 |
| 33 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.74725450 |
| 34 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.73831393 |
| 35 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.68229557 |
| 36 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.63933548 |
| 37 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.62934850 |
| 38 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.62014371 |
| 39 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.60729822 |
| 40 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.57713682 |
| 41 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.53452890 |
| 42 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.53452890 |
| 43 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.51771834 |
| 44 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.51771834 |
| 45 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.51771834 |
| 46 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.51470482 |
| 47 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.48890154 |
| 48 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.48462960 |
| 49 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.46992615 |
| 50 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.46928610 |
| 51 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.45511525 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.44389429 |
| 53 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.42852785 |
| 54 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.40620556 |
| 55 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.39450245 |
| 56 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.38007261 |
| 57 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.36166701 |
| 58 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.35839088 |
| 59 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.35007890 |
| 60 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.35006792 |
| 61 | TP53_16413492_ChIP-PET_HCT116_Human | 1.34561251 |
| 62 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.33350346 |
| 63 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.32627192 |
| 64 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.30705709 |
| 65 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30380030 |
| 66 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.29957116 |
| 67 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.29845100 |
| 68 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27734526 |
| 69 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.25694502 |
| 70 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.22153182 |
| 71 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.21913760 |
| 72 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.21913760 |
| 73 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.19933703 |
| 74 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.19927285 |
| 75 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19700206 |
| 76 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.18191179 |
| 77 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.17333130 |
| 78 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.17284181 |
| 79 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.16517632 |
| 80 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.15669206 |
| 81 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.14872784 |
| 82 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.14152455 |
| 83 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.13648039 |
| 84 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.13314169 |
| 85 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.12286553 |
| 86 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.10574864 |
| 87 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10104012 |
| 88 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.08946716 |
| 89 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.08197033 |
| 90 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07362234 |
| 91 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.07222952 |
| 92 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.06856229 |
| 93 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.04862378 |
| 94 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04514923 |
| 95 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.04202925 |
| 96 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.04148441 |
| 97 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03889064 |
| 98 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02653916 |
| 99 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.00137989 |
| 100 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.99569246 |
| 101 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99536243 |
| 102 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.99480152 |
| 103 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.99351192 |
| 104 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.98861298 |
| 105 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.98731757 |
| 106 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.98279568 |
| 107 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.97624956 |
| 108 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96602786 |
| 109 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96531521 |
| 110 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.94351330 |
| 111 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93517427 |
| 112 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.93468102 |
| 113 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.93166900 |
| 114 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93023452 |
| 115 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.92695091 |
| 116 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.92042924 |
| 117 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.91185577 |
| 118 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.90870641 |
| 119 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.90783199 |
| 120 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.90145517 |
| 121 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.89363564 |
| 122 | KDM2B_26808549_Chip-Seq_K562_Human | 0.88788165 |
| 123 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87708617 |
| 124 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.87688817 |
| 125 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.87174226 |
| 126 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.87103515 |
| 127 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.86472822 |
| 128 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.85740875 |
| 129 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.85504339 |
| 130 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.85256883 |
| 131 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.84752031 |
| 132 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.84444935 |
| 133 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.84205973 |
| 134 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.81440561 |
| 135 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.79835128 |
| 136 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.79813682 |
| 137 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.79756516 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.17658949 |
| 2 | MP0005503_abnormal_tendon_morphology | 4.03807860 |
| 3 | MP0009384_cardiac_valve_regurgitation | 3.32969243 |
| 4 | MP0005275_abnormal_skin_tensile | 3.32593329 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 3.22413991 |
| 6 | MP0000751_myopathy | 3.19737998 |
| 7 | MP0003279_aneurysm | 3.04598621 |
| 8 | MP0004272_abnormal_basement_membrane | 2.95355951 |
| 9 | MP0004084_abnormal_cardiac_muscle | 2.80341862 |
| 10 | MP0010368_abnormal_lymphatic_system | 2.78814408 |
| 11 | MP0003646_muscle_fatigue | 2.70147655 |
| 12 | MP0001958_emphysema | 2.65050973 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.48234169 |
| 14 | MP0003011_delayed_dark_adaptation | 2.46318236 |
| 15 | MP0001879_abnormal_lymphatic_vessel | 2.36718768 |
| 16 | MP0005084_abnormal_gallbladder_morpholo | 2.33939306 |
| 17 | MP0004215_abnormal_myocardial_fiber | 2.24803854 |
| 18 | MP0005330_cardiomyopathy | 2.22784555 |
| 19 | MP0002282_abnormal_trachea_morphology | 2.12246124 |
| 20 | MP0009250_abnormal_appendicular_skeleto | 2.07741208 |
| 21 | MP0000749_muscle_degeneration | 2.07674653 |
| 22 | MP0006138_congestive_heart_failure | 2.04526728 |
| 23 | MP0002822_catalepsy | 2.02449315 |
| 24 | MP0002108_abnormal_muscle_morphology | 2.02285843 |
| 25 | MP0004484_altered_response_of | 2.01323182 |
| 26 | MP0003828_pulmonary_edema | 1.83334569 |
| 27 | MP0002972_abnormal_cardiac_muscle | 1.82455456 |
| 28 | MP0004036_abnormal_muscle_relaxation | 1.81790732 |
| 29 | MP0000750_abnormal_muscle_regeneration | 1.81626119 |
| 30 | MP0005623_abnormal_meninges_morphology | 1.73854908 |
| 31 | MP0002249_abnormal_larynx_morphology | 1.73527749 |
| 32 | MP0003950_abnormal_plasma_membrane | 1.70605512 |
| 33 | MP0000163_abnormal_cartilage_morphology | 1.66847610 |
| 34 | MP0002796_impaired_skin_barrier | 1.66783457 |
| 35 | MP0005508_abnormal_skeleton_morphology | 1.66275445 |
| 36 | MP0005499_abnormal_olfactory_system | 1.65522293 |
| 37 | MP0005394_taste/olfaction_phenotype | 1.65522293 |
| 38 | MP0003941_abnormal_skin_development | 1.65517502 |
| 39 | MP0005620_abnormal_muscle_contractility | 1.63521202 |
| 40 | MP0004087_abnormal_muscle_fiber | 1.60368205 |
| 41 | MP0004133_heterotaxia | 1.58445473 |
| 42 | MP0009780_abnormal_chondrocyte_physiolo | 1.57443769 |
| 43 | MP0001544_abnormal_cardiovascular_syste | 1.55016439 |
| 44 | MP0005385_cardiovascular_system_phenoty | 1.55016439 |
| 45 | MP0000383_abnormal_hair_follicle | 1.54427734 |
| 46 | MP0010030_abnormal_orbit_morphology | 1.52914139 |
| 47 | MP0000049_abnormal_middle_ear | 1.50376656 |
| 48 | MP0008789_abnormal_olfactory_epithelium | 1.49728434 |
| 49 | MP0002933_joint_inflammation | 1.49457585 |
| 50 | MP0010630_abnormal_cardiac_muscle | 1.48145725 |
| 51 | MP0002896_abnormal_bone_mineralization | 1.47069330 |
| 52 | MP0000767_abnormal_smooth_muscle | 1.46922067 |
| 53 | MP0004858_abnormal_nervous_system | 1.45038183 |
| 54 | MP0000762_abnormal_tongue_morphology | 1.44102004 |
| 55 | MP0003566_abnormal_cell_adhesion | 1.43088726 |
| 56 | MP0000462_abnormal_digestive_system | 1.42928963 |
| 57 | MP0002295_abnormal_pulmonary_circulatio | 1.40819230 |
| 58 | MP0000566_synostosis | 1.40318402 |
| 59 | MP0002127_abnormal_cardiovascular_syste | 1.40031943 |
| 60 | MP0008775_abnormal_heart_ventricle | 1.39709503 |
| 61 | MP0000579_abnormal_nail_morphology | 1.38919125 |
| 62 | MP0002653_abnormal_ependyma_morphology | 1.37243738 |
| 63 | MP0000003_abnormal_adipose_tissue | 1.36979008 |
| 64 | MP0003136_yellow_coat_color | 1.34688315 |
| 65 | MP0002009_preneoplasia | 1.32684275 |
| 66 | MP0004085_abnormal_heartbeat | 1.31838050 |
| 67 | MP0005167_abnormal_blood-brain_barrier | 1.26946282 |
| 68 | MP0002877_abnormal_melanocyte_morpholog | 1.25454792 |
| 69 | MP0005369_muscle_phenotype | 1.24361854 |
| 70 | MP0002234_abnormal_pharynx_morphology | 1.24265812 |
| 71 | MP0006054_spinal_hemorrhage | 1.23272440 |
| 72 | MP0003385_abnormal_body_wall | 1.21725904 |
| 73 | MP0002060_abnormal_skin_morphology | 1.21389370 |
| 74 | MP0002115_abnormal_skeleton_extremities | 1.21301402 |
| 75 | MP0000537_abnormal_urethra_morphology | 1.20415218 |
| 76 | MP0004134_abnormal_chest_morphology | 1.20149073 |
| 77 | MP0000343_altered_response_to | 1.17128518 |
| 78 | MP0000759_abnormal_skeletal_muscle | 1.15294469 |
| 79 | MP0003137_abnormal_impulse_conducting | 1.14745120 |
| 80 | MP0002106_abnormal_muscle_physiology | 1.12260609 |
| 81 | MP0004233_abnormal_muscle_weight | 1.11053459 |
| 82 | MP0005501_abnormal_skin_physiology | 1.10637457 |
| 83 | MP0002098_abnormal_vibrissa_morphology | 1.10526311 |
| 84 | MP0005365_abnormal_bile_salt | 1.10421023 |
| 85 | MP0000733_abnormal_muscle_development | 1.09239186 |
| 86 | MP0001270_distended_abdomen | 1.08539661 |
| 87 | MP0005165_increased_susceptibility_to | 1.06196237 |
| 88 | MP0008260_abnormal_autophagy | 1.04897774 |
| 89 | MP0001542_abnormal_bone_strength | 1.04649068 |
| 90 | MP0005670_abnormal_white_adipose | 1.03559210 |
| 91 | MP0002113_abnormal_skeleton_development | 1.03499348 |
| 92 | MP0005023_abnormal_wound_healing | 1.03188605 |
| 93 | MP0005390_skeleton_phenotype | 1.02342513 |
| 94 | MP0004264_abnormal_extraembryonic_tissu | 1.01922441 |
| 95 | MP0005666_abnormal_adipose_tissue | 1.00916422 |
| 96 | MP0010678_abnormal_skin_adnexa | 0.99584627 |
| 97 | MP0002638_abnormal_pupillary_reflex | 0.99181898 |
| 98 | MP0008995_early_reproductive_senescence | 0.98592770 |
| 99 | MP0005409_darkened_coat_color | 0.98502850 |
| 100 | MP0002128_abnormal_blood_circulation | 0.98084676 |
| 101 | MP0004782_abnormal_surfactant_physiolog | 0.97562076 |
| 102 | MP0000613_abnormal_salivary_gland | 0.94317129 |
| 103 | MP0003724_increased_susceptibility_to | 0.93002948 |
| 104 | MP0001299_abnormal_eye_distance/ | 0.92674568 |
| 105 | MP0005595_abnormal_vascular_smooth | 0.90297989 |
| 106 | MP0003935_abnormal_craniofacial_develop | 0.90000977 |
| 107 | MP0003938_abnormal_ear_development | 0.89672879 |
| 108 | MP0002332_abnormal_exercise_endurance | 0.89327877 |
| 109 | MP0003119_abnormal_digestive_system | 0.86528145 |
| 110 | MP0005257_abnormal_intraocular_pressure | 0.86201265 |
| 111 | MP0003091_abnormal_cell_migration | 0.85745812 |
| 112 | MP0004130_abnormal_muscle_cell | 0.85467668 |
| 113 | MP0002925_abnormal_cardiovascular_devel | 0.84130298 |
| 114 | MP0003755_abnormal_palate_morphology | 0.84067513 |
| 115 | MP0000026_abnormal_inner_ear | 0.83547973 |
| 116 | MP0002233_abnormal_nose_morphology | 0.83460197 |
| 117 | MP0000266_abnormal_heart_morphology | 0.83207643 |
| 118 | MP0000516_abnormal_urinary_system | 0.83149308 |
| 119 | MP0005367_renal/urinary_system_phenotyp | 0.83149308 |
| 120 | MP0002133_abnormal_respiratory_system | 0.82805712 |
| 121 | MP0005388_respiratory_system_phenotype | 0.82805712 |
| 122 | MP0000465_gastrointestinal_hemorrhage | 0.82181984 |
| 123 | MP0001849_ear_inflammation | 0.81703004 |
| 124 | MP0002932_abnormal_joint_morphology | 0.81506254 |
| 125 | MP0001529_abnormal_vocalization | 0.80743651 |
| 126 | MP0000678_abnormal_parathyroid_gland | 0.80600511 |
| 127 | MP0000467_abnormal_esophagus_morphology | 0.79680174 |
| 128 | MP0002116_abnormal_craniofacial_bone | 0.79569268 |
| 129 | MP0005164_abnormal_response_to | 0.79308752 |
| 130 | MP0000534_abnormal_ureter_morphology | 0.79156430 |
| 131 | MP0005375_adipose_tissue_phenotype | 0.78859249 |
| 132 | MP0000230_abnormal_systemic_arterial | 0.78689589 |
| 133 | MP0004185_abnormal_adipocyte_glucose | 0.76863272 |
| 134 | MP0001614_abnormal_blood_vessel | 0.76610824 |
| 135 | MP0002751_abnormal_autonomic_nervous | 0.76478105 |
| 136 | MP0003942_abnormal_urinary_system | 0.76448252 |
| 137 | MP0002269_muscular_atrophy | 0.76013067 |
| 138 | MP0000013_abnormal_adipose_tissue | 0.75977000 |
| 139 | MP0002109_abnormal_limb_morphology | 0.75865316 |
| 140 | MP0003115_abnormal_respiratory_system | 0.75338557 |
| 141 | MP0005197_abnormal_uvea_morphology | 0.74722970 |
| 142 | MP0009672_abnormal_birth_weight | 0.73859520 |
| 143 | MP0010771_integument_phenotype | 0.73139977 |
| 144 | MP0005171_absent_coat_pigmentation | 0.73034105 |
| 145 | MP0000538_abnormal_urinary_bladder | 0.72843936 |
| 146 | MP0003191_abnormal_cellular_cholesterol | 0.72033660 |
| 147 | MP0004885_abnormal_endolymph | 0.66558475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thick nail (HP:0001805) | 5.00716316 |
| 2 | Epiphyseal dysplasia (HP:0002656) | 4.66782130 |
| 3 | Enlarged penis (HP:0000040) | 4.42415623 |
| 4 | Long foot (HP:0001833) | 4.23150376 |
| 5 | Neonatal short-limb short stature (HP:0008921) | 4.22899275 |
| 6 | Growth hormone excess (HP:0000845) | 4.22636141 |
| 7 | Hypoplastic ischia (HP:0003175) | 4.18990162 |
| 8 | Protrusio acetabuli (HP:0003179) | 4.12251343 |
| 9 | Premature rupture of membranes (HP:0001788) | 4.02610458 |
| 10 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 4.02016492 |
| 11 | Elfin facies (HP:0004428) | 3.91462186 |
| 12 | Muscle fiber splitting (HP:0003555) | 3.88377226 |
| 13 | Increased connective tissue (HP:0009025) | 3.66335881 |
| 14 | Abnormality of the ischium (HP:0003174) | 3.64187807 |
| 15 | Hypoglycemic seizures (HP:0002173) | 3.46040862 |
| 16 | Abnormality of the calf musculature (HP:0001430) | 3.40030514 |
| 17 | Irregular epiphyses (HP:0010582) | 3.29749491 |
| 18 | Vitreoretinal degeneration (HP:0000655) | 3.28786476 |
| 19 | Aortic aneurysm (HP:0004942) | 3.28163525 |
| 20 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.27993676 |
| 21 | Cupped ribs (HP:0000887) | 3.27343668 |
| 22 | Sudden death (HP:0001699) | 3.20324788 |
| 23 | Lymphangioma (HP:0100764) | 3.19323543 |
| 24 | Calf muscle hypertrophy (HP:0008981) | 3.14490798 |
| 25 | Ventricular tachycardia (HP:0004756) | 3.11840523 |
| 26 | Right ventricular cardiomyopathy (HP:0011663) | 3.06715664 |
| 27 | Metaphyseal cupping (HP:0003021) | 3.04846877 |
| 28 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.01232720 |
| 29 | Alopecia of scalp (HP:0002293) | 3.00411609 |
| 30 | Aortic dissection (HP:0002647) | 2.97525462 |
| 31 | Advanced eruption of teeth (HP:0006288) | 2.96044570 |
| 32 | Mild short stature (HP:0003502) | 2.92746716 |
| 33 | Spinal rigidity (HP:0003306) | 2.91313484 |
| 34 | Pulmonary artery stenosis (HP:0004415) | 2.91166324 |
| 35 | Atrial fibrillation (HP:0005110) | 2.89671547 |
| 36 | Exercise-induced muscle cramps (HP:0003710) | 2.86648924 |
| 37 | Broad metatarsal (HP:0001783) | 2.84165236 |
| 38 | Congenital, generalized hypertrichosis (HP:0004540) | 2.79987233 |
| 39 | Hypoglycemic coma (HP:0001325) | 2.79821623 |
| 40 | Lipoatrophy (HP:0100578) | 2.74467524 |
| 41 | Abnormal tarsal ossification (HP:0008369) | 2.74104770 |
| 42 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.73977177 |
| 43 | Delayed CNS myelination (HP:0002188) | 2.73350960 |
| 44 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.68843770 |
| 45 | Primary atrial arrhythmia (HP:0001692) | 2.67210707 |
| 46 | Acanthosis nigricans (HP:0000956) | 2.65927979 |
| 47 | Limited hip movement (HP:0008800) | 2.63967160 |
| 48 | Distal lower limb muscle weakness (HP:0009053) | 2.62907683 |
| 49 | Flat acetabular roof (HP:0003180) | 2.59627153 |
| 50 | Metaphyseal dysplasia (HP:0100255) | 2.58376450 |
| 51 | Coxa vara (HP:0002812) | 2.55323936 |
| 52 | Supraventricular arrhythmia (HP:0005115) | 2.54848850 |
| 53 | Supraventricular tachycardia (HP:0004755) | 2.53259358 |
| 54 | Hip contracture (HP:0003273) | 2.51992047 |
| 55 | Osteoarthritis (HP:0002758) | 2.51003956 |
| 56 | Small epiphyses (HP:0010585) | 2.50903396 |
| 57 | Ankle contracture (HP:0006466) | 2.50789031 |
| 58 | Vascular tortuosity (HP:0004948) | 2.47220305 |
| 59 | Hyporeflexia of lower limbs (HP:0002600) | 2.47045531 |
| 60 | Type 1 muscle fiber predominance (HP:0003803) | 2.46464958 |
| 61 | Ulnar claw (HP:0001178) | 2.45903106 |
| 62 | Long toe (HP:0010511) | 2.45724392 |
| 63 | Short hallux (HP:0010109) | 2.45631932 |
| 64 | Flat capital femoral epiphysis (HP:0003370) | 2.44712808 |
| 65 | Cervical subluxation (HP:0003308) | 2.44565393 |
| 66 | Soft skin (HP:0000977) | 2.44294037 |
| 67 | Arterial tortuosity (HP:0005116) | 2.42936431 |
| 68 | Genu varum (HP:0002970) | 2.41636937 |
| 69 | Shallow orbits (HP:0000586) | 2.40920253 |
| 70 | Absent eyelashes (HP:0000561) | 2.40625398 |
| 71 | Atrophic scars (HP:0001075) | 2.39912678 |
| 72 | Split foot (HP:0001839) | 2.39568891 |
| 73 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.38437315 |
| 74 | Wormian bones (HP:0002645) | 2.32811228 |
| 75 | Abnormal vertebral ossification (HP:0100569) | 2.30440422 |
| 76 | Abnormality of the pubic bones (HP:0003172) | 2.27733987 |
| 77 | Renal dysplasia (HP:0000110) | 2.26882232 |
| 78 | Platyspondyly (HP:0000926) | 2.23062668 |
| 79 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.22009730 |
| 80 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.21479530 |
| 81 | Bicornuate uterus (HP:0000813) | 2.20752680 |
| 82 | Abnormality of nail color (HP:0100643) | 2.19033160 |
| 83 | Delayed epiphyseal ossification (HP:0002663) | 2.18852472 |
| 84 | Overgrowth (HP:0001548) | 2.16860928 |
| 85 | Arthropathy (HP:0003040) | 2.15913728 |
| 86 | Follicular hyperkeratosis (HP:0007502) | 2.15797632 |
| 87 | Limb-girdle muscle atrophy (HP:0003797) | 2.15072857 |
| 88 | Symptomatic seizures (HP:0011145) | 2.13185902 |
| 89 | Abnormal foot bone ossification (HP:0010675) | 2.12901039 |
| 90 | Increased variability in muscle fiber diameter (HP:0003557) | 2.12674814 |
| 91 | Subaortic stenosis (HP:0001682) | 2.12415417 |
| 92 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.12415417 |
| 93 | Abnormality of the vertebral endplates (HP:0005106) | 2.10744166 |
| 94 | Exercise-induced myalgia (HP:0003738) | 2.09739716 |
| 95 | Fibular aplasia (HP:0002990) | 2.08134098 |
| 96 | Mesomelia (HP:0003027) | 2.07907970 |
| 97 | EMG: myopathic abnormalities (HP:0003458) | 2.06646272 |
| 98 | Prolonged QT interval (HP:0001657) | 2.03067773 |
| 99 | Adactyly (HP:0009776) | 2.02970208 |
| 100 | Abnormality of dentin (HP:0010299) | 2.01341861 |
| 101 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 2.00533088 |
| 102 | Abnormality of femoral epiphyses (HP:0006499) | 2.00533088 |
| 103 | Aortic regurgitation (HP:0001659) | 2.00175548 |
| 104 | Absent hand (HP:0004050) | 1.98990609 |
| 105 | Cerebral aneurysm (HP:0004944) | 1.97765832 |
| 106 | Dilated cardiomyopathy (HP:0001644) | 1.96714438 |
| 107 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.95811525 |
| 108 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.95504844 |
| 109 | Abnormality of the acetabulum (HP:0003170) | 1.95139474 |
| 110 | Hydroureter (HP:0000072) | 1.94941910 |
| 111 | Wide anterior fontanel (HP:0000260) | 1.94715454 |
| 112 | Bladder diverticulum (HP:0000015) | 1.94607432 |
| 113 | Fibular hypoplasia (HP:0003038) | 1.94523997 |
| 114 | Bronchomalacia (HP:0002780) | 1.94139109 |
| 115 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.93813354 |
| 116 | Wrist flexion contracture (HP:0001239) | 1.93060334 |
| 117 | Occipital encephalocele (HP:0002085) | 1.91518621 |
| 118 | Abnormality of carpal bone ossification (HP:0006257) | 1.91416061 |
| 119 | Waddling gait (HP:0002515) | 1.91165952 |
| 120 | Concave nail (HP:0001598) | 1.91022872 |
| 121 | Back pain (HP:0003418) | 1.91021612 |
| 122 | Irregular vertebral endplates (HP:0003301) | 1.90781893 |
| 123 | Difficulty climbing stairs (HP:0003551) | 1.89209792 |
| 124 | Hyperpituitarism (HP:0010514) | 1.89193597 |
| 125 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.87486501 |
| 126 | Ovoid vertebral bodies (HP:0003300) | 1.86429030 |
| 127 | Fragile skin (HP:0001030) | 1.86276591 |
| 128 | Thin ribs (HP:0000883) | 1.85649884 |
| 129 | Broad ribs (HP:0000885) | 1.84689536 |
| 130 | Exostoses (HP:0100777) | 1.83810901 |
| 131 | Lumbar hyperlordosis (HP:0002938) | 1.83453365 |
| 132 | Down-sloping shoulders (HP:0200021) | 1.82523478 |
| 133 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.82488185 |
| 134 | Microglossia (HP:0000171) | 1.80224007 |
| 135 | Myotonia (HP:0002486) | 1.77732784 |
| 136 | Flattened epiphyses (HP:0003071) | 1.76615720 |
| 137 | Vertebral compression fractures (HP:0002953) | 1.76442640 |
| 138 | Visceral angiomatosis (HP:0100761) | 1.75567712 |
| 139 | Ketoacidosis (HP:0001993) | 1.75546797 |
| 140 | Neoplasm of the heart (HP:0100544) | 1.75077412 |
| 141 | Hypotrichosis (HP:0001006) | 1.73389725 |
| 142 | Abnormality of the pulmonary veins (HP:0011718) | 1.72268233 |
| 143 | Morphological abnormality of the middle ear (HP:0008609) | 1.71104008 |
| 144 | Infantile muscular hypotonia (HP:0008947) | 1.70474682 |
| 145 | Coronal craniosynostosis (HP:0004440) | 1.70049250 |
| 146 | Camptodactyly of toe (HP:0001836) | 1.69510510 |
| 147 | Spastic diplegia (HP:0001264) | 1.67414499 |
| 148 | Hyperventilation (HP:0002883) | 1.64143634 |
| 149 | Esophageal varix (HP:0002040) | 1.62874843 |
| 150 | Keratoconus (HP:0000563) | 1.61966863 |
| 151 | Increased corneal curvature (HP:0100692) | 1.61966863 |
| 152 | Choanal stenosis (HP:0000452) | 1.61001383 |
| 153 | Accelerated skeletal maturation (HP:0005616) | 1.60622156 |
| 154 | Thickened nuchal skin fold (HP:0000474) | 1.60242382 |
| 155 | Intellectual disability, moderate (HP:0002342) | 1.57867251 |
| 156 | Vaginal atresia (HP:0000148) | 1.57157356 |
| 157 | Abdominal distention (HP:0003270) | 1.54819654 |
| 158 | Ectropion (HP:0000656) | 1.54595270 |
| 159 | Hypodontia (HP:0000668) | 1.54231806 |
| 160 | Epidermoid cyst (HP:0200040) | 1.53890970 |
| 161 | Striae distensae (HP:0001065) | 1.53851386 |
| 162 | Abnormality of the anterior chamber (HP:0000593) | 1.51834053 |
| 163 | Unilateral renal agenesis (HP:0000122) | 1.50837100 |
| 164 | Intestinal atresia (HP:0011100) | 1.50643027 |
| 165 | Genital tract atresia (HP:0001827) | 1.49215940 |
| 166 | Absent speech (HP:0001344) | 1.49109309 |
| 167 | Hemangiomatosis (HP:0007461) | 1.48417116 |
| 168 | Joint laxity (HP:0001388) | 1.48028730 |
| 169 | Precocious puberty (HP:0000826) | 1.46114384 |
| 170 | Septo-optic dysplasia (HP:0100842) | 1.46030195 |
| 171 | Osteopenia (HP:0000938) | 1.45867411 |
| 172 | Asymmetry of the thorax (HP:0001555) | 1.45224953 |
| 173 | Heterochromia iridis (HP:0001100) | 1.44595860 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYLK | 4.04620192 |
| 2 | TTN | 3.99818443 |
| 3 | STK38L | 3.58374979 |
| 4 | MAP3K3 | 3.16945546 |
| 5 | DDR2 | 3.13301355 |
| 6 | CASK | 3.02140467 |
| 7 | DMPK | 2.94867173 |
| 8 | EPHB2 | 2.57902074 |
| 9 | TIE1 | 2.52545754 |
| 10 | STK24 | 2.33799252 |
| 11 | MAP2K7 | 2.15903802 |
| 12 | LATS1 | 2.13771629 |
| 13 | PDK2 | 2.09579674 |
| 14 | PHKG2 | 1.97893907 |
| 15 | PHKG1 | 1.97893907 |
| 16 | TESK1 | 1.96246463 |
| 17 | MAP3K4 | 1.90047428 |
| 18 | TRIB3 | 1.89138662 |
| 19 | TGFBR2 | 1.85220857 |
| 20 | PDGFRA | 1.82559207 |
| 21 | INSRR | 1.79262153 |
| 22 | MAP4K2 | 1.77285300 |
| 23 | PAK3 | 1.68837521 |
| 24 | LMTK2 | 1.63246064 |
| 25 | EPHA2 | 1.59784933 |
| 26 | FER | 1.56153398 |
| 27 | TRPM7 | 1.51870189 |
| 28 | PIK3CA | 1.46444099 |
| 29 | MAPK15 | 1.43662715 |
| 30 | MST4 | 1.42601104 |
| 31 | ROCK1 | 1.40600322 |
| 32 | OBSCN | 1.37072592 |
| 33 | PAK2 | 1.36248482 |
| 34 | ZAK | 1.33092587 |
| 35 | EPHA3 | 1.32019739 |
| 36 | RIPK1 | 1.30537012 |
| 37 | PIM2 | 1.28579033 |
| 38 | PDK3 | 1.23532390 |
| 39 | PDK4 | 1.23532390 |
| 40 | WNK4 | 1.22108154 |
| 41 | PRKD1 | 1.21942953 |
| 42 | LATS2 | 1.20700248 |
| 43 | BCKDK | 1.20340934 |
| 44 | PTK2B | 1.13679086 |
| 45 | EPHB1 | 1.12295984 |
| 46 | MAP2K2 | 1.11293957 |
| 47 | DYRK1B | 1.10504129 |
| 48 | NUAK1 | 1.09083233 |
| 49 | BCR | 1.07974793 |
| 50 | TRIM28 | 1.07191434 |
| 51 | ERBB3 | 1.06374527 |
| 52 | MARK1 | 1.03505852 |
| 53 | LIMK1 | 0.99624315 |
| 54 | SIK3 | 0.98706133 |
| 55 | GSK3A | 0.97397363 |
| 56 | KDR | 0.96345705 |
| 57 | STK3 | 0.94145222 |
| 58 | SIK1 | 0.92705828 |
| 59 | ARAF | 0.92469572 |
| 60 | PKN2 | 0.92373311 |
| 61 | MAP2K1 | 0.87403983 |
| 62 | MET | 0.87391037 |
| 63 | RPS6KA2 | 0.84986096 |
| 64 | MAP2K4 | 0.83350811 |
| 65 | CDC42BPA | 0.83116087 |
| 66 | AKT3 | 0.82754776 |
| 67 | ERN1 | 0.81420430 |
| 68 | ROCK2 | 0.80080116 |
| 69 | PRKCE | 0.78492919 |
| 70 | PTK6 | 0.78192164 |
| 71 | ILK | 0.78177738 |
| 72 | MAPK12 | 0.77978004 |
| 73 | ERBB4 | 0.75338382 |
| 74 | PDGFRB | 0.75110240 |
| 75 | NLK | 0.74876260 |
| 76 | PTK2 | 0.73772757 |
| 77 | CAMK2G | 0.73039886 |
| 78 | GRK5 | 0.68289142 |
| 79 | PRKG2 | 0.67827160 |
| 80 | MST1R | 0.67581202 |
| 81 | MAP2K3 | 0.67127341 |
| 82 | PINK1 | 0.66364311 |
| 83 | MAPKAPK3 | 0.66337068 |
| 84 | MAP3K2 | 0.66061771 |
| 85 | NME1 | 0.65509151 |
| 86 | CSNK1A1L | 0.64931398 |
| 87 | CAMK2B | 0.62253224 |
| 88 | PRKAA2 | 0.62132326 |
| 89 | MAP3K6 | 0.61787748 |
| 90 | MUSK | 0.61352672 |
| 91 | GRK7 | 0.61204584 |
| 92 | TAOK1 | 0.61002123 |
| 93 | STK39 | 0.59524140 |
| 94 | MAPK7 | 0.59181104 |
| 95 | TESK2 | 0.58869093 |
| 96 | TAOK2 | 0.57996739 |
| 97 | PRPF4B | 0.56650670 |
| 98 | CDK9 | 0.56528289 |
| 99 | MAPK13 | 0.56263668 |
| 100 | CSNK1G3 | 0.56072568 |
| 101 | MAP3K7 | 0.55198354 |
| 102 | PRKD3 | 0.54817507 |
| 103 | TGFBR1 | 0.54786620 |
| 104 | RPS6KB2 | 0.53430079 |
| 105 | PRKD2 | 0.52300927 |
| 106 | CAMK1D | 0.50854097 |
| 107 | NEK9 | 0.48821969 |
| 108 | PLK2 | 0.47727755 |
| 109 | MARK2 | 0.46501576 |
| 110 | RET | 0.46324341 |
| 111 | PAK4 | 0.46310204 |
| 112 | CAMK2D | 0.46130191 |
| 113 | ICK | 0.45747803 |
| 114 | WNK3 | 0.45295600 |
| 115 | WNK1 | 0.44206776 |
| 116 | BMX | 0.43729605 |
| 117 | NEK6 | 0.43658426 |
| 118 | FRK | 0.43404331 |
| 119 | GRK1 | 0.42617960 |
| 120 | VRK2 | 0.40408852 |
| 121 | PRKCH | 0.40142124 |
| 122 | MKNK2 | 0.39484925 |
| 123 | STK38 | 0.38453099 |
| 124 | DAPK3 | 0.37855790 |
| 125 | FGFR1 | 0.37517962 |
| 126 | DYRK3 | 0.37415555 |
| 127 | MOS | 0.37401495 |
| 128 | CSNK1G2 | 0.36950971 |
| 129 | NTRK2 | 0.36806215 |
| 130 | RPS6KA4 | 0.36295719 |
| 131 | EPHA4 | 0.34834020 |
| 132 | MTOR | 0.34773411 |
| 133 | PRKCZ | 0.33745195 |
| 134 | SCYL2 | 0.33471390 |
| 135 | CHUK | 0.31914237 |
| 136 | NTRK1 | 0.31876811 |
| 137 | LRRK2 | 0.31765994 |
| 138 | GRK6 | 0.31148519 |
| 139 | CSNK1G1 | 0.31132128 |
| 140 | RPS6KL1 | 0.29652569 |
| 141 | RPS6KC1 | 0.29652569 |
| 142 | INSR | 0.29488929 |
| 143 | MAPK9 | 0.27472855 |
| 144 | CAMK4 | 0.27313534 |
| 145 | IGF1R | 0.27246852 |
| 146 | DYRK2 | 0.22540286 |
| 147 | EEF2K | 0.22342542 |
| 148 | ADRBK1 | 0.22308428 |
| 149 | CDK5 | 0.22180833 |
| 150 | AKT2 | 0.22111138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 4.03244547 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.45053162 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.35646983 |
| 4 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 3.13448075 |
| 5 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.92496382 |
| 6 | Focal adhesion_Homo sapiens_hsa04510 | 2.70028416 |
| 7 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.49598434 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.30449370 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.15244782 |
| 10 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.09840353 |
| 11 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.00805351 |
| 12 | Adherens junction_Homo sapiens_hsa04520 | 1.79542979 |
| 13 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.73836043 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.59499044 |
| 15 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.56566999 |
| 16 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.51802438 |
| 17 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.51740692 |
| 18 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.49233175 |
| 19 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.46178859 |
| 20 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.45555576 |
| 21 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.44448899 |
| 22 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.43059095 |
| 23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.41749465 |
| 24 | Amoebiasis_Homo sapiens_hsa05146 | 1.36645866 |
| 25 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.34900675 |
| 26 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.33949556 |
| 27 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.31551862 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.28876997 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.25702520 |
| 30 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.25531481 |
| 31 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.24771755 |
| 32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.24444422 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.22395981 |
| 34 | Prion diseases_Homo sapiens_hsa05020 | 1.21751868 |
| 35 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.19343039 |
| 36 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.17583526 |
| 37 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.14285027 |
| 38 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.14064008 |
| 39 | Malaria_Homo sapiens_hsa05144 | 1.14002411 |
| 40 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.09785846 |
| 41 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.08900624 |
| 42 | Tight junction_Homo sapiens_hsa04530 | 1.06987902 |
| 43 | Sulfur relay system_Homo sapiens_hsa04122 | 1.04622405 |
| 44 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.03005808 |
| 45 | Insulin resistance_Homo sapiens_hsa04931 | 1.01918118 |
| 46 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.99246135 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.98169896 |
| 48 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.96139169 |
| 49 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.95184028 |
| 50 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.93600514 |
| 51 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.93010583 |
| 52 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.92874341 |
| 53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.92392560 |
| 54 | Axon guidance_Homo sapiens_hsa04360 | 0.91281772 |
| 55 | Renin secretion_Homo sapiens_hsa04924 | 0.91214250 |
| 56 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.90875255 |
| 57 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.89519480 |
| 58 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.89398200 |
| 59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88880687 |
| 60 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.87591897 |
| 61 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.87205862 |
| 62 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.85370005 |
| 63 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.85192388 |
| 64 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.85010881 |
| 65 | GABAergic synapse_Homo sapiens_hsa04727 | 0.84551939 |
| 66 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.83582795 |
| 67 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.83015557 |
| 68 | Circadian rhythm_Homo sapiens_hsa04710 | 0.82880838 |
| 69 | Pathways in cancer_Homo sapiens_hsa05200 | 0.81451471 |
| 70 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.81439346 |
| 71 | Parkinsons disease_Homo sapiens_hsa05012 | 0.81429087 |
| 72 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.80343983 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 0.78246023 |
| 74 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.76913867 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76730805 |
| 76 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.75172542 |
| 77 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.74984979 |
| 78 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.74962480 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74440610 |
| 80 | Cocaine addiction_Homo sapiens_hsa05030 | 0.74030537 |
| 81 | Melanoma_Homo sapiens_hsa05218 | 0.73508870 |
| 82 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.73210635 |
| 83 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.72274854 |
| 84 | Histidine metabolism_Homo sapiens_hsa00340 | 0.71136533 |
| 85 | Alzheimers disease_Homo sapiens_hsa05010 | 0.71034135 |
| 86 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.70325611 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.68564223 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68555442 |
| 89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67192164 |
| 90 | Gap junction_Homo sapiens_hsa04540 | 0.66771122 |
| 91 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.66557149 |
| 92 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.66412237 |
| 93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65200470 |
| 94 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64812446 |
| 95 | Prostate cancer_Homo sapiens_hsa05215 | 0.63440538 |
| 96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63192137 |
| 97 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.63046424 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.62990811 |
| 99 | Melanogenesis_Homo sapiens_hsa04916 | 0.62593385 |
| 100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62475465 |
| 101 | Bile secretion_Homo sapiens_hsa04976 | 0.62083519 |
| 102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60989543 |
| 103 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60438038 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59934691 |
| 105 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.59931154 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.58071710 |
| 107 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.57765699 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57513331 |
| 109 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.57419561 |
| 110 | Platelet activation_Homo sapiens_hsa04611 | 0.57294295 |
| 111 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.57005546 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55295525 |
| 113 | Carbon metabolism_Homo sapiens_hsa01200 | 0.54750272 |
| 114 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54588175 |
| 115 | Lysine degradation_Homo sapiens_hsa00310 | 0.54539758 |
| 116 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.53550128 |
| 117 | Huntingtons disease_Homo sapiens_hsa05016 | 0.53530270 |
| 118 | Morphine addiction_Homo sapiens_hsa05032 | 0.53166063 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53059287 |
| 120 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.52813541 |
| 121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51984940 |
| 122 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.51806078 |
| 123 | Bladder cancer_Homo sapiens_hsa05219 | 0.51648602 |
| 124 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.51298402 |
| 125 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.51196096 |
| 126 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50050667 |
| 127 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.49856629 |
| 128 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.49750026 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.49735949 |
| 130 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.49084794 |
| 131 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.47802782 |
| 132 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47558189 |
| 133 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.47475501 |
| 134 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47347715 |
| 135 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47247029 |
| 136 | Mineral absorption_Homo sapiens_hsa04978 | 0.47083659 |
| 137 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.46925509 |
| 138 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46186409 |
| 139 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.46161674 |
| 140 | Peroxisome_Homo sapiens_hsa04146 | 0.45104447 |
| 141 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.45011077 |
| 142 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44967335 |
| 143 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.44404608 |
| 144 | Retinol metabolism_Homo sapiens_hsa00830 | 0.43563235 |
| 145 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.41375200 |

